The standard treatment for Chronic Myeloid Leukemia and other cancer types requires Imatinib Tablets IP 400 mg. The medicine belongs to a group of targeted therapies that work by blocking certain proteins responsible for the growth of cancer cells. The treatment restricts abnormal cell movement which enables physicians to manage the disease with greater success. The targeted cancer th... https://quickbloging.com/how-imatinib-tablets-ip-400-mg-help-manage-chronic-myeloid-leukemia/